Federal contractor profile

SPEED BIOSYSTEMS, LLC

UEI NEBAJX4Q5NJ5CAGE 6KCG3Company website ↗

Active
Small Business

Overview

Legal name
SPEED BIOSYSTEMS, LLC
Also known as
SPEED BIOSYSTEMS LLC
Registered location
POTOMAC, MD, USA
Website
Company website ↗
Primary NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity
Sep 25, 2025
Read company summary

SPEED BIOSYSTEMS, LLC is associated with UEI NEBAJX4Q5NJ5 and CAGE 6KCG3 in public federal records. AcornBids currently links 2 prime awards totaling $395.8K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing; Biological Product (except Diagnostic) Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists POTOMAC, MD, USA.

At a glance

Lifetime prime obligations$395.8K
Prime awards2
Awards with future end dates0
Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 16, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name
SPEED BIOSYSTEMS, LLC
Doing business as
SPEED BIOSYSTEMS LLC
UEI
NEBAJX4Q5NJ5
CAGE
6KCG3
Registered address
10120 LIMESTONE CT, POTOMAC, MD, 20854, USA
Registration status
Active
Primary NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation
Nov 6, 2025
Initial registration
Oct 13, 2011
Entity start
Aug 11, 2011
SAM updated
Nov 6, 2025
Registration expires
Nov 4, 2026
Fiscal year end
Dec 31
Place of incorporation
MD, USA

View SAM.gov source

Research brief

Source facts

  • Loaded prime-award records link 2 awards and $395,790 in reported obligations to this legal entity. Source
  • Recorded awards include In-Vitro Diagnostic Substance Manufacturing (NAICS 325413); this classification is not proof of every company capability. Source
  • An example award describes: TURBO293 TRANSFECTION REAGENT FOR HEK293 CELLS QTY 78 (AMBIS #2269961) Source

Federal award analysis

Net transaction obligations by federal fiscal period.

Selected transaction obligations$395.8K
Prime contracts

Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 2 of 2 selected awards. Select a period to explore its awards.

Funding change

Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.

MeasureReported value
Current periodOct 1, 2025 – Sep 30, 2026
Current obligationsNot reported
Prior periodOct 1, 2024 – Sep 30, 2025
Prior obligations$395.8K
ChangeNot reported
GrowthNot comparable

Where the work is performed

AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL

State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.

Agencies
CategoryPeriod obligationsAwards
Department of Health and Human Services$395.8K2
Offices
CategoryPeriod obligationsAwards
NATIONAL INSTITUTES OF HEALTH NIAID$395.8K2
Naics
Psc
CategoryPeriod obligationsAwards
6505 — Drugs and Biologicals$395.8K2
Vehicles
CategoryPeriod obligationsAwards
Unclassified$395.8K2
States
CategoryPeriod obligationsAwards
MD$395.8K2
Set Asides
CategoryPeriod obligationsAwards
NO SET ASIDE USED.$395.8K2

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / descriptionAwarding agencyObligationsStart dateEnd date
75N93025P01091TURBO293 TRANSFECTION REAGENT FOR HEK293 CELLS QTY 78 (AMBIS #2269961)Department of Health and Human Services$248.9KSep 26, 2025Sep 25, 2026
75N93025P00268SPEED BIOSYSTEMS TURBO293 TRANSFECTION REAGENTSDepartment of Health and Human Services$146.9KJan 23, 2025Apr 30, 2025

Registration, certifications & contacts

Registration evidenceDate
SAM updatedNov 6, 2025
Source loadedSep 26, 2026
Initial registrationOct 13, 2011
Entity startAug 11, 2011

Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.

IndustryReported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)Not reported
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Not reported
ContactRolePublished contact methodsEvidenceSource date
DAZHI LAIGovernment businessContact method not publishedSAM registrationNot available
DAZHI LAIElectronic businessContact method not publishedSAM registrationNot available
Registered industries
  • 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
  • 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registered products and services
  • B504 — Chemical/Biological Studies and Analysis

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source

Related companies worth researching

Explore the customer, work and award-size evidence behind each match.

HARDY DIAGNOSTICS

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
7 awards

FISHER SCIENTIFIC COMPANY L.L.C.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

10X GENOMICS, INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
50 awards

BECTON, DICKINSON AND COMPANY

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
3 awards

LIFE TECHNOLOGIES CORPORATION

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
17 awards

REVVITY HEALTH SCIENCES, INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing, 325414 — Biological Product (except Diagnostic) Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
9 awards
Data coverage and methodology

Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.

Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.

Keep your research moving

Save this company, track changes, and evaluate upcoming work against your targets.

Save to my research Find my fit